Science with a Twist – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Science with a Twist

Thermo Fisher

Science

Frequency: 1 episode/55d. Total Eps: 42

It’s almost impossible to overstate how many aspects of daily life are impacted by science. From technologies that help ensure the quality of the water we drink, to medicines that deliver lifesaving treatments – it’s all thanks to science. Each month, members of Thermo Fisher Scientific's team talk to experts who are on the cutting-edge of redefining how we exist. This is Science with a Twist.

Read moreCollapse

Site

RSS

Apple

Data updated on 04/07/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

Good

Score global : 73%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

From Organ Donation to Drug Safety: The Power of HLA

Season 3 · Episode 5

Thursday, September 25, 2025 • Duration 27:02

How is a decades-old scientific tool that revolutionized organ transplantation now being used in cancer immunotherapy and autoimmune disease?

In this episode of Science with a Twist, host Terri Somers talks to experts in immunogenetics and histocompatibility about human leukocyte antigens, or HLAs, which are biomarkers on our cells that provide crucial information about our immune system. HLAs have been used for decades now to match the right donated organ or cells to a patient in need. As science has gained a deeper understanding of the immune system, the utility of HLAs has expanded significantly, helping to transform healthcare.

Guests-at-a-Glance

 Name: Marcelo Fernandez Vina
💡 What they do: Director, Histocompatibility & Immunogenetics Laboratory
💡 Company: Stanford Blood Center
💡 Noteworthy: International leader in HLA research with over 30 years of lab and academic experience
💡 Where to find him: LinkedIn

💡 Name: Dave Lowe
💡 What they do: Senior Director, R&D – Transplant Diagnostics
💡 Company: Thermo Fisher Scientific
💡 Noteworthy: Leads global development of HLA testing tools for transplant and immunogenetics
💡 Where to find him: LinkedIn

Read moreCollapse

Gene Therapy: A New Era of Medicine Bringing Fresh Hope to Patients

Season 3 · Episode 4

Monday, July 14, 2025 • Duration 27:55

Imagine a future where diseases like leukemia, sickle cell anemia and multiple sclerosis are no longer life sentences, but treatable and even curable. That is the promise of gene therapy.

In this episode, Namritha Ravinder, director of cell biology at Thermo Fisher Scientific, explains the groundbreaking technologies that correct the genetic errors in our cells that lead to disease. These gene therapies may offer permanent solutions with single-dose treatments. Namritha also provides an expert’s view on what’s to come from more than 2,000 gene therapies in the pipeline, and the innovation needed to make these new treatments accessible to patients.

Read moreCollapse

Advancing Sustainability in Laboratories: A Conversation with My Green Lab’s James Connelly and Thermo Fisher Scientific’s Alyssa Caddle

Season 3 · Episode 3

Thursday, April 17, 2025 • Duration 34:13

Laboratories use up to ten times the energy of typical office spaces, making sustainability in science a pressing issue. In this episode of Science with a Twist, host Terri Somers speaks with James Connelly, CEO of My Green Lab, and Alyssa Caddle, Senior Director of Global Sustainability at Thermo Fisher Scientific, about steps laboratories can take to reduce their environmental impact.

From energy-efficient cold storage to sustainable lab products, James and Alyssa discuss how the life science industry is evolving to meet ambitious climate goals.

Read moreCollapse

Enabling Healthier Communities: Thermo Fisher's Impact

Season 3 · Episode 2

Thursday, July 11, 2024 • Duration 32:29

Listen to the conversation as they discuss:

How health equity is a key component of Thermo Fisher’s core business.
How Thermo Fisher leverages its capabilities and customer relationships to further its impact.
Initiatives that improve health equity through accessibility to drug-resistant HIV testing, next-generation sequencing to diagnose lung and breast cancer in 30 underserved countries, increasing the accessibility to and diversity in clinical trials, and more.
New programs in 2024.

Read moreCollapse

Access to Clinical Trials: Eliminating Barriers to Enrollment for Women

Season 3 · Episode 1

Tuesday, June 25, 2024 • Duration 19:32

Dr. Blackburne shares insights into:

The challenges of recruiting women and minority groups for clinical trials, noting the logistical and societal barriers they face.
Innovative solutions, such as telemedicine and flexible scheduling, to make trial participation more accessible.
Recent advances in clinical research, including a groundbreaking preeclampsia test and contributions to COVID-19 vaccine trials, highlighting Thermo Fisher's pivotal role in these developments.

Read moreCollapse

From Waste to Worth: Rethinking Plastics with NREL's Insights

Season 2 · Episode 20

Monday, April 22, 2024 • Duration 29:00

The Critical Role of Plastics in Modern Society

Despite the challenges associated with plastic in the environment, Kat Knauer, Ph.D., emphasizes the indispensable role of plastics in healthcare, research, and daily life. She points out that while plastics have significantly improved quality of life and medical care, their improper disposal poses a significant threat to the environment. She advocates for a balanced approach to improving plastics use, suggesting that the answer lies not in eliminating plastics altogether but in innovating more sustainable management and recycling practices. This nuanced perspective encourages listeners to appreciate the benefits of plastics while acknowledging the urgency of addressing their environmental impact.

Innovations in Plastic Recycling and Sustainability

Kat introduces groundbreaking work on the development of sustainable technologies for recycling plastics and designing new materials that are recyclable by design. She highlights the BOTTLE Consortium's efforts in chemically upcycling existing plastic waste streams and creating plastics that are more compatible with the environment. This initiative reflects a significant shift towards reducing reliance on single-use plastics and fossil fuels, aiming for a circular economy where the life cycle of a plastic is extended through recycling and reuse. Kat's discussion on these innovations offers hope for a future where plastic pollution is significantly mitigated through scientific research and technological advancement.

Collaboration as a Key to Tackling Plastic Pollution

The conversation underscores the importance of collaboration across different sectors to address the plastic waste crisis. Kat mentions partnerships with companies like Amazon and Patagonia, which are working towards creating more sustainable packaging solutions and textile recycling methods. These collaborations illustrate how combining efforts from the scientific community, industry leaders, and consumers can lead to innovative solutions that promote a more sustainable future. Calling for increased collaboration and communication to bridge gaps in the recycling process, Kat also offers tips for more responsible consumption and disposal practices among consumers.

It’s In Our Genes: The Potential of Gene Therapy with Dr. Peter Marks

Season 2 · Episode 19

Wednesday, March 6, 2024 • Duration 24:58

Gene Therapy's Potential to Transform Rare Disease Treatment

Dr. Peter Marks highlights the groundbreaking advancements in gene therapy, especially for rare diseases with high unmet medical needs. He discusses the FDA's role in fostering these innovations, underscoring the importance of understanding gene therapy's application and ensuring its safe delivery. Dr. Marks emphasizes the challenges in manufacturing gene therapies, noting that overcoming these hurdles is essential for treating large populations and common diseases. This insight reflects on the hope and complexity of gene therapy, aiming to provide one-time treatments that could drastically improve patient outcomes.

The Role of AI in Enhancing Gene Therapy Development

Dr. Marks points out the significant potential use cases for artificial intelligence (AI) in gene therapy, from product design to clinical development and manufacturing. AI’s ability to predict off-target effects and streamline the manufacturing process could be a game-changer in this space. By harnessing AI, researchers and developers can optimize safety signals and process large quantities of data for continuous improvement. This insight underscores the potential of AI to revolutionize gene therapy, making it more efficient and effective.

Emphasizing the Human Impact of Gene Therapies

Dr. Marks and Miller share personal stories of patients and families affected by rare diseases, illustrating the transformative power of gene therapy. They recount profound effects of recent gene therapy approvals on individuals and their communities, particularly highlighting Duchenne Muscular Dystrophy. Marks's narrative conveys the deep emotional and physical impact of gene therapy, not just as a scientific achievement but as a means to significantly enhance lives. This insight brings to light the importance of patient-centered approaches in the development and application of gene therapies.

Read moreCollapse

Decoding Cellular Secrets: Advances in Mass Spectrometry Technology

Season 2 · Episode 18

Thursday, December 21, 2023 • Duration 19:31

Revolutionizing Biomedical Research with Mass Spectrometry

Joshua J. Coon discusses the transformative role of mass spectrometry in biomedical research. This technology, as he explains, allows for the precise weighing of molecules, providing critical insights into their identity and quantity. Coon's lab utilizes mass spectrometry to analyze complex biological systems, such as cells and tissues, identifying over 10,000 molecules in a single sample. This capability has significant implications for understanding genetic and lifestyle influences on molecular behavior in organisms. Coon's work exemplifies how a fundamental scientific tool can lead to profound discoveries in disease mechanisms and potential treatments.

Linking Unknown Proteins to Disease: A New Frontier

Coon highlights a groundbreaking project where his team investigates proteins of unknown function, particularly those involved in metabolism and located in mitochondria. By creating cell lines with each lacking a different protein and then using mass spectrometry to analyze the resulting molecular changes, they can infer relationships between known and unknown proteins. This approach has led to identifying the functions of several proteins and linking them to specific human disorders. This research is not only pioneering in its method but also crucial in laying the groundwork for new therapies, as understanding protein functions can lead to targeted drug development.

Personal Journey: From Rural Roots to Research Leader

Joshua J. Coon shares his personal journey, beginning in rural Michigan, where his early interests in science and woodworking led him to the field of mass spectrometry. His path took him through the University of Florida for his PhD and the University of Virginia for postdoctoral studies, culminating in leading his research group at the University of Wisconsin-Madison. Joshua emphasizes the joy of training the next generation of scientists, with his lab producing over 50 PhD students and postdocs who are now contributing significantly to science globally. This insight not only sheds light on Coon's professional achievements but also highlights his role in mentoring and shaping future scientific leaders.

Tackling HIV Drug Resistance: Brazil's Approach and Global Implications

Season 2 · Episode 17

Wednesday, November 29, 2023 • Duration 35:52

Brazil's Proactive Measures Against HIV

Brazil has been at the forefront of combating HIV, implementing proactive measures that have made a significant difference. The country began providing no-cost access to CD4 and viral load testing and antiretroviral drugs as early as 1996. This early intervention and consistent approach led to a remarkable outcome: the number of HIV cases in Brazil was significantly lower than initially predicted. An article from the New England Journal of Medicine stated that initial estimates predicted Brazil would have 1.2 million people infected with HIV by the year 2000, but with the strategies the country put in place, their actual numbers were about half of what was predicted. By offering free access to treatments and diagnostic tests, Brazil showcased the importance of early and sustained intervention in managing and reducing the spread of HIV.

The Rising Challenge of HIV Drug Resistance

One of the most pressing challenges in the fight against HIV is the development of drug resistance. Dr. Ricardo Diaz emphasizes that as the HIV virus replicates, it can produce strains resistant to treatment. This resistance threatens the efficacy of antiretroviral drugs, making it crucial to monitor and manage. The World Health Organization reports an increasing rate of HIV drug resistance, underscoring the need for continuous research, monitoring, and adaptation of treatment strategies.

Pre-exposure Prophylaxis (PrEP) Drugs Exist, but are not 100% Effective

PrEP, or pre-exposure prophylaxis, is also an antiretroviral drug given to uninfected individuals who are at risk of infection to reduce their chances of acquiring HIV. PrEP is highly effective at preventing HIV when taken as indicated, but much less effective when it isn't taken consistently. Additionally, it's possible to be exposed to HIV strains that are drug resistant while on PrEP, so monitoring resistance in people on PrEP is another important step in prevention.

Powering Everyday Life: The significance and impacts of the semiconductor industry

Season 2 · Episode 16

Wednesday, September 27, 2023 • Duration 19:09

⚡Semiconductor chips go through a long manufacturing process. It all depends on the type of chip, but the standard timeframe is between 120 days and nine months. It is a three-phase process that includes design and frontend and backend manufacturing, all dependent on various factors. ''These are global supply chains supporting the completed product. Semiconductor chips could be manufactured by a large fab, maybe most of it within the house, but there are diversified approaches too, where the chip is moving across the country to complete certain stages of manufacturing.''

⚡Some companies don't produce semiconductors in-house. The rationale behind such a decision lies in the need for a specific environment and certain conditions for making these chips. ''The fabs themselves are like huge low cities. All of this has to be clean room work. It needs to be done within one location generally. So because it's clean room work, you can't send that across until a critical step is completed in the manufacturing process. [...] If even a dust molecule were to land on any of these chips, the dust molecule's width is wide enough to block the passes of electrical current on the chip, thus making the chip ineffective," explains Geoff.

⚡We use a wide range of gases to prevent impurities from harming the chips. The most commonly used are helium, nitrogen, argon, and hydrogen. However, the gases used must be in perfect condition. And that's Mark's job. ''My experience is mostly with mass spectrometry, which is one of the best ways to analyze compounds like this. Specifically, an API-MS — an atmospheric pressure ionization mass spectrometer — has a simplified analysis of big bulk gases. For example, in the past 20 or 30 years, you could not analyze oxygen, if you could not get down low detection limits, analyze oxygen in bulk nitrogen. That used to be a lot more difficult with traditional techniques. But Thermo Fisher Scientific has put out some new analyzers with such a low detection limit there that we can accurately say we will get 10 to 15 parts per trillion in our gases that are being put through all these processes.''

Science with a Twist – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Science with a Twist – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

LinkedIn2

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

LinkedIn2

Apple Podcasts

Spotify